BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durand JK, Baldwin AS. Targeting IKK and NF-κB for Therapy. Adv Protein Chem Struct Biol 2017;107:77-115. [PMID: 28215229 DOI: 10.1016/bs.apcsb.2016.11.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Puar YR, Shanmugam MK, Fan L, Arfuso F, Sethi G, Tergaonkar V. Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression. Biomedicines 2018;6:E82. [PMID: 30060453 DOI: 10.3390/biomedicines6030082] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 24.3] [Reference Citation Analysis]
2 Lecoeur H, Prina E, Rosazza T, Kokou K, N’diaye P, Aulner N, Varet H, Bussotti G, Xing Y, Milon G, Weil R, Meng G, Späth GF. Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response. Cell Reports 2020;30:1870-1882.e4. [DOI: 10.1016/j.celrep.2020.01.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
3 Xu Y, Wang Y, Pang X, Li Z, Wu J, Zhou Z, Xu T, Gobin Beharee R, Jin L, Yu J. Potassium dihydrogen phosphate promotes the proliferation and differentiation of human periodontal ligament stem cells via nuclear factor kappa B pathway. Exp Cell Res 2019;384:111593. [PMID: 31487508 DOI: 10.1016/j.yexcr.2019.111593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Wang L, Lu S, Wang L, Xin M, Xu Y, Wang G, Chen D, Chen L, Liu S, Zhao F. Anti-inflammatory effects of three withanolides isolated from Physalis angulata L. in LPS-activated RAW 264.7 cells through blocking NF-κB signaling pathway. J Ethnopharmacol 2021;276:114186. [PMID: 33957208 DOI: 10.1016/j.jep.2021.114186] [Reference Citation Analysis]
5 Zhang Y, Shao J, Li S, Liu Y, Zheng M. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma. Front Oncol 2021;11:775250. [PMID: 34804980 DOI: 10.3389/fonc.2021.775250] [Reference Citation Analysis]
6 Chatterjee R, Chatterjee J. ROS and oncogenesis with special reference to EMT and stemness. Eur J Cell Biol 2020;99:151073. [PMID: 32201025 DOI: 10.1016/j.ejcb.2020.151073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
7 Ma C, Liu M, Zhang J, Cai H, Wu Y, Zhang Y, Ji Y, Shan H, Zou Z, Yang L, Liu L, Xu H, Lei H, Liu C, Zhou L, Cao Y, Zhou H, Wu Y. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway. Chem Biol Interact 2022;351:109770. [PMID: 34861246 DOI: 10.1016/j.cbi.2021.109770] [Reference Citation Analysis]
8 Hsueh CS, Wu CH, Shih CH, Yeh JL, Jeng CR, Pang VF, Chiou HY, Chang HW. Role of nuclear factor-kappa B in feline injection site sarcoma. BMC Vet Res 2019;15:365. [PMID: 31653220 DOI: 10.1186/s12917-019-2100-9] [Reference Citation Analysis]
9 Hodges JK, Sasaki GY, Bruno RS. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. J Nutr Biochem 2020;85:108478. [PMID: 32801031 DOI: 10.1016/j.jnutbio.2020.108478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 El-ashmawy NE, El-zamarany EA, Khedr EG, Abo-saif MA. Activation of EMT in colorectal cancer by MTDH/NF-κB p65 pathway. Mol Cell Biochem 2019;457:83-91. [DOI: 10.1007/s11010-019-03514-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Liu L, Xu L, Wang S, Wang L, Wang X, Xu H, Li X, Ye H. Confirmation of inhibitingTLR4/MyD88/NF-κB Signalling Pathway by Duhuo Jisheng Decoction on Osteoarthritis: A Network Pharmacology Approach-Integrated Experimental Study. Front Pharmacol 2022;12:784822. [DOI: 10.3389/fphar.2021.784822] [Reference Citation Analysis]
12 Song N, Thaiss F, Guo L. NFκB and Kidney Injury. Front Immunol 2019;10:815. [PMID: 31040851 DOI: 10.3389/fimmu.2019.00815] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
13 Zhang R, Guo N, Yan G, Wang Q, Gao T, Zhang B, Hou N. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway. Int J Mol Med 2021;47:62. [PMID: 33649807 DOI: 10.3892/ijmm.2021.4895] [Reference Citation Analysis]
14 Cai BQ, Chen WM, Zhao J, Hou W, Tang JC. Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo. J Oncol 2021;2021:9355555. [PMID: 34795760 DOI: 10.1155/2021/9355555] [Reference Citation Analysis]
15 O'Garro C, Igbineweka L, Ali Z, Mezei M, Mujtaba S. The Biological Significance of Targeting Acetylation-Mediated Gene Regulation for Designing New Mechanistic Tools and Potential Therapeutics. Biomolecules 2021;11:455. [PMID: 33803759 DOI: 10.3390/biom11030455] [Reference Citation Analysis]
16 Zhang R, Xu L, Zhang D, Hu B, Luo Q, Han D, Li J, Shen C. Cardioprotection of Ginkgolide B on Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Regulation of A20-NF-κB Pathway. Front Immunol 2018;9:2844. [PMID: 30619251 DOI: 10.3389/fimmu.2018.02844] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
17 Saha S, Kiran M, Kuscu C, Chatrath A, Wotton D, Mayo MW, Dutta A. Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation. Cancer Res 2020;80:950-63. [PMID: 31900260 DOI: 10.1158/0008-5472.CAN-19-3460] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
18 Zhang H, Ren QC, Ren Y, Zhao L, Yang F, Zhang Y, Zhao WJ, Tan YZ, Shen XF. Ajudecumin A from Ajuga ovalifolia var. calantha exhibits anti-inflammatory activity in lipopolysaccharide-activated RAW264.7 murine macrophages and animal models of acute inflammation. Pharm Biol 2018;56:649-57. [PMID: 31070535 DOI: 10.1080/13880209.2018.1543331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Fordjour FA, Asiedu E, Larbi A, Kwarteng A. The role of nuclear factor kappa B (NF-κB) in filarial pathology. J Cell Commun Signal 2021;15:185-93. [PMID: 33630268 DOI: 10.1007/s12079-021-00607-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M. Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it. Exp Biol Med (Maywood) 2019;244:1-12. [PMID: 30661394 DOI: 10.1177/1535370218824538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
21 Li Q, Chen Y, Zhang D, Grossman J, Li L, Khurana N, Jiang H, Grierson PM, Herndon J, DeNardo DG, Challen GA, Liu J, Ruzinova MB, Fields RC, Lim KH. IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer. JCI Insight 2019;4:130867. [PMID: 31527315 DOI: 10.1172/jci.insight.130867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 You C, Zu J, Liu X, Kong P, Song C, Wei R, Zhou C, Wang Y, Yan J. Synovial fibroblast-targeting liposomes encapsulating an NF-κB-blocking peptide ameliorates zymosan-induced synovial inflammation. J Cell Mol Med 2018;22:2449-57. [PMID: 29383874 DOI: 10.1111/jcmm.13549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lei Q, Yi T, Chen C. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction. Med Sci Monit 2018;24:6044-52. [PMID: 30161099 DOI: 10.12659/MSM.908529] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]
24 Zhang R, Han D, Li Z, Shen C, Zhang Y, Li J, Yan G, Li S, Hu B, Li J, Liu P. Ginkgolide C Alleviates Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Inhibition of CD40-NF-κB Pathway. Front Pharmacol 2018;9:109. [PMID: 29515442 DOI: 10.3389/fphar.2018.00109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
25 Walter CEJ, Durairajan S, Periyandavan K, C GPD, G DJD, A HRV, Johnson T, Zayed H. Bladder neoplasms and NF-κB: an unfathomed association. Expert Rev Mol Diagn 2020;20:497-508. [PMID: 32228251 DOI: 10.1080/14737159.2020.1743688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Marzaro G, Lampronti I, D'aversa E, Sacchetti G, Miolo G, Vaccarin C, Cabrini G, Dechecchi MC, Gambari R, Chilin A. Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB). European Journal of Medicinal Chemistry 2018;151:285-93. [DOI: 10.1016/j.ejmech.2018.03.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Vancurova I, Uddin MM, Zou Y, Vancura A. Combination Therapies Targeting HDAC and IKK in Solid Tumors. Trends Pharmacol Sci 2018;39:295-306. [PMID: 29233541 DOI: 10.1016/j.tips.2017.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
28 Chen Y, Guo S, Jiang K, Wang Y, Yang M, Guo M. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice. Int Immunopharmacol 2019;75:105749. [PMID: 31306981 DOI: 10.1016/j.intimp.2019.105749] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
29 Zhang L, Leng TD, Yang T, Li J, Xiong ZG. Protein Kinase C Regulates ASIC1a Protein Expression and Channel Function via NF-kB Signaling Pathway. Mol Neurobiol 2020;57:4754-66. [PMID: 32783140 DOI: 10.1007/s12035-020-02056-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Na HK, Yang H, Surh YJ. 15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis in Ha-ras-transformed Human Breast Epithelial Cells by Targeting IκB kinase-NF-κB Signaling. J Cancer Prev 2020;25:100-10. [PMID: 32647651 DOI: 10.15430/JCP.2020.25.2.100] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Saraei R, Marofi F, Naimi A, Talebi M, Ghaebi M, Javan N, Salimi O, Hassanzadeh A. Leukemia therapy by flavonoids: Future and involved mechanisms. J Cell Physiol 2019;234:8203-20. [PMID: 30500074 DOI: 10.1002/jcp.27628] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Li Y, Wang Y, Zou W. Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke. Front Aging Neurosci 2022;14:814463. [DOI: 10.3389/fnagi.2022.814463] [Reference Citation Analysis]
33 Akgun S, Kucuksayan H, Ozes ON, Can O, Alikanoglu AS, Yildiz M, Akca H. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN. Anticancer Agents Med Chem 2019;19:1058-68. [PMID: 30727918 DOI: 10.2174/1871520619666190206165215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, Tian Y, Liu L, Su M, Wang H, Cao D, Liao Q. Role of the NFκB-signaling pathway in cancer. Onco Targets Ther 2018;11:2063-73. [PMID: 29695914 DOI: 10.2147/OTT.S161109] [Cited by in Crossref: 91] [Cited by in F6Publishing: 60] [Article Influence: 22.8] [Reference Citation Analysis]
35 Tong H, Huang Z, Chen H, Zhou B, Liao Y, Wang Z. Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway. Onco Targets Ther 2020;13:9839-48. [PMID: 33061461 DOI: 10.2147/OTT.S253691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yu T, Yu Q, Chen X, Zhou L, Wang Y, Yu C. Exclusive enteral nutrition protects against inflammatory bowel disease by inhibiting NF‑κB activation through regulation of the p38/MSK1 pathway. Int J Mol Med 2018;42:1305-16. [PMID: 29901086 DOI: 10.3892/ijmm.2018.3713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Elkamhawy A, Kim NY, Hassan AHE, Park JE, Yang JE, Oh KS, Lee BH, Lee MY, Shin KJ, Lee KT, Hur W, Roh EJ. Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators. Eur J Med Chem 2018;157:691-704. [PMID: 30130718 DOI: 10.1016/j.ejmech.2018.08.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
38 Wang T, Zhang J, Hou T, Yin X, Zhang N. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy. Nanoscale 2019;11:13934-46. [PMID: 31305839 DOI: 10.1039/c9nr03374b] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 11.7] [Reference Citation Analysis]
39 Lu SL, Chang JH, Huang CF, Chen LS. Therapeutic potential of proteasome inhibitors for dihydropyridine-induced gingival overgrowth. Oral Dis 2020;26:630-6. [PMID: 31856317 DOI: 10.1111/odi.13260] [Reference Citation Analysis]
40 Santoro R, Carbone C, Piro G, Chiao PJ, Melisi D. TAK -ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy. Drug Resistance Updates 2017;33-35:36-42. [DOI: 10.1016/j.drup.2017.10.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
41 Elkamhawy A, Kim NY, Hassan AHE, Park JE, Paik S, Yang JE, Oh KS, Lee BH, Lee MY, Shin KJ, Pae AN, Lee KT, Roh EJ. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents. Eur J Med Chem 2020;188:111955. [PMID: 31893550 DOI: 10.1016/j.ejmech.2019.111955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
42 Elkamhawy A, Youn Kim N, Hassan AHE, Park JE, Yang JE, Elsherbeny MH, Paik S, Oh KS, Lee BH, Lee MY, Shin KJ, Pae AN, Lee KT, Roh EJ. Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation. Bioorg Chem 2019;92:103261. [PMID: 31542718 DOI: 10.1016/j.bioorg.2019.103261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H, Bai Y, Guo J, Su Z. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther 2021;222:107752. [PMID: 33253739 DOI: 10.1016/j.pharmthera.2020.107752] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Singh SP, Singh NI, Nongalleima K, Doley P, Singh CB, Sahoo D. Molecular docking, MD simulation, DFT and ADME-toxicity study on analogs of zerumbone against IKK-β enzyme as anti-cancer agents. Netw Model Anal Health Inform Bioinforma 2018;7. [DOI: 10.1007/s13721-018-0171-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
45 Baig MS, Roy A, Saqib U, Rajpoot S, Srivastava M, Naim A, Liu D, Saluja R, Faisal SM, Pan Q, Turkowski K, Darwhekar GN, Savai R. Repurposing Thioridazine (TDZ) as an anti-inflammatory agent. Sci Rep 2018;8:12471. [PMID: 30127400 DOI: 10.1038/s41598-018-30763-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
46 Fochi S, Mutascio S, Bertazzoni U, Zipeto D, Romanelli MG. HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role. Front Microbiol 2018;9:285. [PMID: 29515558 DOI: 10.3389/fmicb.2018.00285] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
47 Wang X, Wang Y, Zhou X, Liu F. Conditioned Medium from Adipose-Derived Stem Cell Inhibits Jurkat Cell Proliferation through TGF-β1 and p38/MAPK Pathway. Anal Cell Pathol (Amst) 2019;2019:2107414. [PMID: 31934530 DOI: 10.1155/2019/2107414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Sheng P, Zhu H, Zhang W, Xu Y, Peng W, Sun J, Gu M, Jiang H. The immunoglobulin superfamily member 3 (IGSF3) promotes hepatocellular carcinoma progression through activation of the NF-κB pathway. Ann Transl Med 2020;8:378. [PMID: 32355822 DOI: 10.21037/atm.2020.02.14] [Reference Citation Analysis]
49 Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A. Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway. Eur J Pharmacol 2018;839:33-9. [PMID: 30244004 DOI: 10.1016/j.ejphar.2018.09.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
50 Yang L, Zhou G, Liu J, Song J, Zhang Z, Huang Q, Wei F. Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF-κB. Biomed Pharmacother 2021;137:111353. [PMID: 33578236 DOI: 10.1016/j.biopha.2021.111353] [Reference Citation Analysis]
51 Abdellatef AA, Zhou Y, Yamada A, Elmekkawy SA, Kohyama A, Yokoyama S, Meselhy MR, Matsuya Y, Sakurai H, Hayakawa Y. Synthetic E-guggulsterone derivative GSD-1 inhibits NF-κB signaling and suppresses the metastatic potential of breast cancer cells. Biomed Pharmacother 2021;140:111737. [PMID: 34020249 DOI: 10.1016/j.biopha.2021.111737] [Reference Citation Analysis]
52 Yamamoto M, Gohda J, Akiyama T, Inoue JI. TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:145-60. [PMID: 33840674 DOI: 10.2183/pjab.97.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Escoté X. Potential clinical treatment of colitis with cardiotrophin-1. Clin Sci (Lond) 2018;132:2169-74. [PMID: 30341227 DOI: 10.1042/CS20171626] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Prieto-Vicente V, Sánchez-Garrido AI, Blanco-Gozalo V, Arévalo M, García-Sánchez E, López-Montañés D, Quiros Y, López-Hernández FJ, Rodríguez-Pérez A, López-Novoa JM. Cardiotrophin-1 attenuates experimental colitis in mice. Clin Sci (Lond) 2018;132:985-1001. [PMID: 29572384 DOI: 10.1042/CS20171513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]